nach oben

Current Diabetes Reports

Erschienen in:

01.01.2016 | Diabetes and Pregnancy (CJ Homko, Section Editor)

Is There a Role for HbA1c in Pregnancy?

verfasst von: Ruth C. E. Hughes, Janet Rowan, Chris M. Florkowski

Erschienen in: Current Diabetes Reports | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Outside pregnancy, HbA1c analysis is used for monitoring, screening for and diagnosing diabetes and prediabetes. During pregnancy, the role for HbA1c analysis is not yet established. Physiological changes lower HbA1c levels, and pregnancy-specific reference ranges may need to be recognised. Other factors that influence HbA1c are also important to consider, particularly since emerging data suggest that, in early pregnancy, HbA1c elevations close to the reference range may both identify women with underlying hyperglycaemia and be associated with adverse pregnancy outcomes. In later pregnancy, HbA1c analysis is less useful than an oral glucose tolerance test (OGTT) at detecting gestational diabetes. Postpartum, HbA1c analysis detects fewer women with abnormal glucose tolerance than an OGTT, but the ease of testing may improve follow-up rates and combining HbA1c analysis with fasting plasma glucose or waist circumference may improve detection rates. This article discusses the relevance of HbA1c testing at different stages of pregnancy.

Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.CrossRefPubMed

WHO: Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy [http://www.who.int/diabetes/publications/Hyperglycaemia_In_Pregnancy/en/] Accessed on: 10 August 2015.

American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38 Suppl:S8-S16. doi:10.2337/dc15-S005.

Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRefPubMed

Jiao Y, Okumiya T, Saibara T, et al. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care. 1998;21(10):1732–5.CrossRefPubMed

Lind T, Billewicz WZ, Brown G. A serial study of changes occurring in the oral glucose tolerance test during pregnancy. J Obstet Gynaecol Br Commonw. 1973;80(12):1033–9.CrossRefPubMed

Worth R, Potter JM, Drury J. Glycosylated haemoglobin in normal pregnancy: a longitudinal study with two independent methods. Diabetologia. 1985;28(2):76–9.PubMed

Ahmad J, Rafat D. HbA1c and iron deficiency: a review. Diabetes Metab Syndr. 2013;7(2):118–22.CrossRefPubMed

Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126–8.CrossRefPubMed

10.

El-Agouza I, Abu Shahla A, Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24(5):285–9.CrossRefPubMed

11.•

Rafat D, Rabbani TK, Ahmad J, et al. Influence of iron metabolism indices on HbA1c in non-diabetic pregnant women with and without iron-deficiency anemia: effect of iron supplementation. Diabetes Metab Syndr. 2012;6(2):102–5. This study reports the changes to HbA1c levels in pregnant women associated with iron deficiency and subsequent iron replacement.CrossRefPubMed

12.

Kim C, Bullard KM, Herman WH, et al. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2010;33(4):780–5.PubMedCentralCrossRefPubMed

13.

NGSP: HbA1c methods: effects of hemoglobin variants (HbC, HbS, HbE and HbD traits) and elevated fetal hemoglobin (HbF). [http://www.ngsp.org/interf.asp] Accessed on 10 August 2015.

14.

Braatvedt G, Cundy T, Crooke M, et al. Understanding the new HbA1c units for the diagnosis of type 2 diabetes. NZ Med J. 2012;125(1362):70–80.

15.

Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770–7.CrossRefPubMed

16.

Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453–7.PubMedCentralCrossRefPubMed

17.

Likhari T, Gama R. Glycaemia-independent ethnic differences in HbA(1c) in subjects with impaired glucose tolerance. Diabet Med. 2009;26(10):1068–9.CrossRefPubMed

18.

Mostafa SA, Davies MJ, Webb DR, et al. Independent effect of ethnicity on glycemia in South Asians and white Europeans. Diabetes Care. 2012;35(8):1746–8.PubMedCentralCrossRefPubMed

19.

Florkowski C. HbA1c as a diagnostic test for diabetes mellitus—reviewing the evidence. Clin Biochem Rev. 2013;34:75–83.PubMedCentralPubMed

20.

Versantvoort AR, van Roosmalen J, Radder JK. Course of HbA1c in non-diabetic pregnancy related to birth weight. Neth J Med. 2013;71(1):22–5.PubMed

21.

O’Shea P, O’Connor C, Owens L, et al. Trimester-specific reference intervals for IFCC standardised haemoglobin A(1c): new criterion to diagnose gestational diabetes mellitus (GDM)? Ir Med J. 2012;105(5 Suppl):29–31.PubMed

22.

Hiramatsu Y, Shimizu I, Omori Y, et al. Determination of reference intervals of glycated albumin and hemoglobin A1c in healthy pregnant Japanese women and analysis of their time courses and influencing factors during pregnancy. Endocr J. 2012;59(2):145–51.CrossRefPubMed

23.

Mosca A, Paleari R, Dalfra MG, et al. Reference intervals for hemoglobin Alc in pregnant women: data from an Italian multicenter study. Clin Chem. 2006;52(6):1138–43.CrossRefPubMed

24.

Radder JK, van Roosmalen J. HbAIC in healthy, pregnant women. Neth J Med. 2005;63(7):256–9.PubMed

25.

Nielsen L, Ekbom P, Damm P, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27(5):1200–1.CrossRefPubMed

26.

O’Kane MJ, Lynch PLM, Moles KW, et al. Determination of a diabetes control and complications trial-aligned HbA1c reference range in pregnancy. Clin Chim Acta. 2001;311(2):157–9.CrossRefPubMed

27.

National Institute for Health and Care Excellence: Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. [https://www.nice.org.uk/guidance/ng3] Accessed on: 10 August 2015.

28.

Temple R, Aldridge V, Greenwood R, et al. Association between outcomes of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ. 2002;325(7375):1275–6.PubMedCentralCrossRefPubMed

29.

Dunne FP, Avalos G, Durkan M, et al. ATLANTIC DIP: pregnancy outcome for women with pregestational diabetes along the Irish Atlantic seaboard. Diabetes Care. 2009;32(7):1205–6.PubMedCentralCrossRefPubMed

30.

Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32(6):1046–8.PubMedCentralCrossRefPubMed

31.

Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med. 2011;28(9):1060–7.PubMedCentralCrossRefPubMed

32.

Tennant PW, Glinianaia SV, Bilous RW, et al. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57(2):285–94.CrossRefPubMed

33.

Cundy T, Gamble G, Neale L, et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes. Diabetes Care. 2007;30(10):2603–7.CrossRefPubMed

34.

Balsells M, Garcia-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009;94(11):4284–91.CrossRefPubMed

35.

Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007;30(7):1920–5.CrossRefPubMed

36.•

Bell R, Glinianaia S, Tennant PWG, Bilous R, Rankin J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55(4):936–947. This study reports useful data for clinicians to accurately give advice about risk of anomaly to women with pre-existing diabetes.

37.•

Hughes RC, Moore MP, Gullam JE, et al. An early pregnancy HbA1c >/=5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953–9. This study defines a useful pregnancy HbA1c threshold to identify women with pre-existing but undiagnosed diabetes. It also shows that this HbA1c threshold is a marker for adverse pregnancy outcomes such as congenital anomalies, preterm delivery, pre-eclampsia, shoulder dystocia and possibly peri-natal death.CrossRefPubMed

38.•

Glinianaia SV, Tennant PW, Bilous RW, et al. HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia. 2012;55(12):3193–203. This study shows the influence of hyperglycaemia on fetal growth and important interactions between early and later HbA1c measures.CrossRefPubMed

39.

Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes. 2011;2(11):196–203.PubMedCentralPubMed

40.

Holmes VA, Young IS, Patterson CC, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34(8):1683–8.PubMedCentralCrossRefPubMed

41.

Damm P, Mersebach H, Rastam J, et al. Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester. J Matern Fetal Neonatal Med. 2014;27(2):149–54.PubMedCentralCrossRefPubMed

42.

Evers IM, de Valk HW, Mol BW, et al. Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia. 2002;45(11):1484–9.CrossRefPubMed

43.

Kerssen A, de Valk HW, Visser GH. Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care. 2007;30(5):1069–74.CrossRefPubMed

44.

Penney GC, Mair G, Pearson DW. The relationship between birth weight and maternal glycated haemoglobin (HbA1c) concentration in pregnancies complicated by type 1 diabetes. Diabet Med. 2003;20(2):162–6.CrossRefPubMed

45.•

Maresh MJ, Holmes VA, Patterson CC, et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015;38(1):34–42. Useful data to recommend that HbA1c <42 mmol/mol (6.0%) through pregnancy should be the target in women with pre-existing diabetes.CrossRefPubMed

46.

Capula C, Mazza T, Vero R, et al. HbA1c levels in patients with gestational diabetes mellitus: relationship with pre-pregnancy BMI and pregnancy outcome. J Endocrinol Investig. 2013;36(11):1038–45.

47.

Barnes RA, Edghill N, Mackenzie J, et al. Predictors of large and small for gestational age birthweight in offspring of women with gestational diabetes mellitus. Diabet Med. 2013;30(9):1040–6.CrossRefPubMed

48.

Rowan JA, Gao W, Hague WM, et al. Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial. Diabetes Care. 2010;33(1):9–16.PubMedCentralCrossRefPubMed

49.

Katon J, Reiber G, Williams MA, et al. Antenatal haemoglobin A1c and risk of large-for-gestational-age infants in a multi-ethnic cohort of women with gestational diabetes. Paediatr Perinat Epidemiol. 2012;26(3):208–17.CrossRefPubMed

50.

Barrett H, Nitert MD, McIntyre HD, et al. Predictors of preeclampsia in women in the Metformin in Gestational Diabetes (Mig) Study. J Diabetes Metab. 2014;5(7):395.CrossRef

51.

Crowther C, Hiller J, Moss J, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–86.CrossRefPubMed

52.

Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48.PubMedCentralCrossRefPubMed

53.

Karcaaltincaba D, Yalvac S, Kandemir O, et al. Glycosylated hemoglobin level in the second trimester predicts birth weight and amniotic fluid volume in non-diabetic pregnancies with abnormal screening test. J Matern Fetal Neonatal Med. 2010;23(10):1193–9.CrossRefPubMed

54.

Nayak AU, Duff CJ, Indusekhar R, et al. Adverse foetal outcomes in women at risk of gestational diabetes with normal OGTT: exploring the role of HbA1c in risk prediction. In: 50th Annual Meeting of the European Association for the Study of Diabetes, EASD 2014: 15-19th Sept 2014; Vienna. Diabetologia. 2014;57(Suppl 1): S447, Abstract 1088.

55.

Ensenauer R, Gmach J, Nehring I, et al. Increased hemoglobin A(1c) in obese pregnant women after exclusion of gestational diabetes. Clin Chem. 2012;58(7):1152–4.CrossRefPubMed

56.•

Alunni ML, Roeder HA, Moore TR, et al. First trimester gestational diabetes screening—change in incidence and pharmacotherapy need. Diabetes Res Clin Pract. 2015;109(1):135–40. A retrospective report of first trimester diabetes screening with HbA1c and FPG in a large cohort of women in California.CrossRefPubMed

57.

McGrath NM, Baker C, Simkins A. Increased detection of gestational diabetes mellitus by using HbA screening in the first antenatal blood tests. Diabet Med. 2014;31(10):1277.

58.•

Rowan JA, Budden A, Sadler LC. Women with a nondiagnostic 75 g glucose tolerance test but elevated HbA1c in pregnancy: an additional group of women with gestational diabetes. Aust N Z J Obstet Gynaecol. 2014;54(2):177–80. A small study, but it demonstrates that an HbA1c threshold ≥41mmol/mol (5.9%) identifies women with hyperglycaemia in pregnancy and therefore may be considered as an adjunct test for GDM in women with a non-diagnostic OGTT, but where there is high clinical suspicion (eg obese woman with macrosomic fetus).CrossRefPubMed

59.

Rowan JA, Budden A, Ivanova V, et al. Women with an HbA of 41-49 mmol/mol (5.9-6.6%): a higher risk subgroup that may benefit from early pregnancy intervention. Diabet Med. 2015;33(1):25–31.

60.

Osmundson S, Norton M, El-Sayed Y, et al. Early treatment of women with prediabetes in pregnancy: a randomized controlled trial. In: 35th Annual Meeting of the Society for Maternal-Fetal Medicine: The Pregnancy Meeting.: 02-07 Feb 2015; San Diego. Am J Obstet Gynecol. 2015;212(1): S23-S24, abstract 35.

61.

Lowe LP, Metzger BE, Dyer AR, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012;35(3):574–80.PubMedCentralCrossRefPubMed

62.

Fong A, Serra AE, Gabby L, et al. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol. 2014;211(6):641 e1–e7.CrossRefPubMed

63.

Balaji V, Madhuri BS, Ashalatha S, et al. A1C in gestational diabetes mellitus in Asian Indian women. Diabetes Care. 2007;30(7):1865–7.CrossRefPubMed

64.

Anaka O, Houlihan C, Beim R, et al. Does first-trimester hemoglobin A1C predict gestational diabetes and fetal outcome? In: 62nd Annual Clinical Meeting of the American College of Obstetricians and Gynecologists: 26-30th April 2014; Chicago. Obstet Gynecol. 2014;123 (Suppl 1): 38S-39S.

65.

Willems D, Moreno YBL, Barglazan D, et al. HbA1c and screening of gestational diabetes. In: EuroMedLab: 21-25th June 2015; Paris. Clin Chem Lab Med. 2015;53(Special Suppl): S664, Abstract T065.

66.

Berggren E, Boggess K, Mathew L, et al. First trimester HbA1c, at clinically normal values, may be an early predictor of third trimester gestational diabetes. In: 35th Annual Meeting of the Society for Maternal-Fetal Medicine: The Pregnancy Meeting.: 02-07 Feb 2015; San Diego. Am J Obstet Gynecol. 2015;212(1): S168-S169, Abstract 312.

67.

Sevket O, Sevket A, Ozel A, et al. The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus. J Obstet Gynaecol Br Commonw. 2014;34(8):690–2.CrossRef

68.

Rajput R, Yogesh Y, Rajput M, et al. Utility of HbA1c for diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2012;98(1):104–7.CrossRefPubMed

69.

Sugiyama T, Saito M, Nishigori H, et al. Comparison of pregnancy outcomes between women with gestational diabetes and overt diabetes first diagnosed in pregnancy: a retrospective multi-institutional study in Japan. Diabetes Res Clin Pract. 2014;103(1):20–5.CrossRefPubMed

70.

Agarwal M, Dhatt G, Punnose J, et al. Gestational diabetes: a reappraisal of HbA1c as a screening test. Acta Obstet Gynecol Scand. 2005;84(12):1159–63.CrossRefPubMed

71.

Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.CrossRefPubMed

72.

Keely E. An opportunity not to be missed—how do we improve postpartum screening rates for women with gestational diabetes? Diabetes Metab Res Rev. 2012;28(4):312–6.CrossRefPubMed

73.

Benaiges D, Chillaron JJ, Pedro-Botet J, et al. Role of A1c in the postpartum screening of women with gestational diabetes. Gynecol Endocrinol. 2013;29(7):687–90.CrossRefPubMed

74.

Picon MJ, Murri M, Munoz A, et al. Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening. Diabetes Care. 2012;35(8):1648–53.PubMedCentralCrossRefPubMed

75.

Shah BR, Lipscombe LL, Feig DS, et al. Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study. Br J Obstet Gynaecol. 2011;118(12):1484–90.CrossRef

76.

McGrath NM, Coats A, Barach O. Improved post-partum follow-up of patients with gestational diabetes mellitus using HbA1c. Diabet Med. 2013;30(10):1264–5.CrossRefPubMed

77.

Megia A, Naf S, Herranz L, et al. The usefulness of HbA1c in postpartum reclassification of gestational diabetes. Br J Obstet Gynaecol. 2012;119(7):891–4.CrossRef

78.

Kim C, Herman WH, Cheung NW, et al. Comparison of hemoglobin A1c with fasting plasma glucose and 2-h postchallenge glucose for risk stratification among women with recent gestational diabetes mellitus. Diabetes Care. 2011;34(9):1949–51.PubMedCentralCrossRefPubMed

79.

Su X, Zhang Z, Qu X, et al. Hemoglobin A1c for diagnosis of postpartum abnormal glucose tolerance among women with gestational diabetes mellitus: diagnostic meta-analysis. PLoS One. 2014;9(7):e102144.PubMedCentralCrossRefPubMed

80.

Noctor E, Crowe C, Carmody LA, et al. ATLANTIC DIP: simplifying the follow-up of women with previous gestational diabetes. Eur J Endocrinol. 2013;169(5):681–7.CrossRefPubMed

81.•

Gobl CS, Bozkurt L, Yarragudi R, et al. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? Acta Diabetol. 2014;51(5):715–722. This paper includes an excellent discussion on the usefulness of postpartum HbA1c analysis, suggesting that serial measures of HbA1c are more useful than a single postnatal test.

82.

Claesson R, Ekelund M, Ignell C, et al. Role of HbA1c in post-partum screening of women with gestational diabetes mellitus. J Clin Translational Endocrinol. 2015;2(1):21–5.CrossRef

83.

Gingras V, Tchernof A, Weisnagel SJ, et al. Use of glycated hemoglobin and waist circumference for diabetic screening in women with a history of gestational diabetes. J Obstet Gynaecol Can. 2013;35(9):810–5.CrossRefPubMed

Titel: Is There a Role for HbA1c in Pregnancy?
verfasst von: Ruth C. E. Hughes
Janet Rowan
Chris M. Florkowski
Publikationsdatum: 01.01.2016
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 1/2016
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-015-0698-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Type 2 Diabetes and Hearing Impairment

Does Metformin Reduce Cancer Risks? Methodologic Considerations

Wolfram Syndrome: Diagnosis, Management, and Treatment

GLP-1 and Amylin in the Treatment of Obesity

Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance